Sanofi

Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection
NY Times, NY
Thu, 11/8/12 - 10:22 pm
drug pricing
Sanofi
Sloan Kettering
colon cancer
Zaltrap
5 Companies Dominating Diabetes
Motley Fool
Tue, 11/6/12 - 04:21 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Sanofi
Novo Nordisk
MannKind
New Drugs for Lipids Set Off Race
NY Times, NY
Tue, 11/6/12 - 12:07 pm
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
Pfizer
Roche
Is Big Pharma Dangerously Betting on Huge, Fragile Product Shots?
Forbes
Mon, 11/5/12 - 11:15 am
Big Pharma
Sanofi
Regeneron, Sanofi Take Step Forward With Cholesterol Drug
Minyanville
Mon, 11/5/12 - 11:05 am
Regeneron
Sanofi
PCSK9
LDL cholesterol
Amgen
AMG145
SAR236553/REGN727
Sanofi draws fire over cost of MS drug Lemtrada
Reuters
Thu, 11/1/12 - 11:51 am
MS
multiple sclerosis
Sanofi
Lemtrada
Neuralstem Swinging For The ALS Fences
Seeking Alpha
Mon, 10/29/12 - 11:39 am
Neuralstem
ALS
Avanir
Geron
StemCells
NeoStem
Sanofi
New Developments In Lipids To Watch Closely
Seeking Alpha
Sun, 10/28/12 - 11:31 am
Lpath
Pfizer
iSONEP
Asonept
macular degeneration
multiple sclerosis
MS
Regeneron
Roche
Bayer
Sanofi
Valeant Pharmaceuticals
GSK
Pharma Drug Wars: Two Winners and One Loser
Wall Street Cheat Street
Sat, 10/27/12 - 11:39 am
Novartis
AstraZeneca
Sanofi
Sanofi's CEO On The New York Times' Criticism Of Drug Prices And Surviving The Patent Cliff
Forbes
Fri, 10/26/12 - 10:31 am
Sanofi
Pharma CEOs
drug pricing
Chris Viehbacher
patents
Sanofi earnings slump in Q3 as competition heats up
Yahoo/AP
Thu, 10/25/12 - 10:53 am
earnings
Sanofi
3 Diabetes Phase 3 Wins
Motley Fool
Tue, 10/23/12 - 04:19 pm
Merck
Sanofi
Eli Lilly
diabetes
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Amylin
4 European Pharmaceuticals Paying Substantial Dividends
Seeking Alpha
Sun, 10/21/12 - 10:53 am
AstraZeneca
GSK
Novartis
Sanofi
This Week in Biotech
Motley Fool
Sun, 10/21/12 - 10:47 am
Aegerion
Isis Pharmaceuticals
Sanofi
NPS Pharmaceuticals
Aeterna Zentaris
Isis Pharma/Genzyme FDA Panel Live Blog
TheStreet.com
Thu, 10/18/12 - 11:39 am
Genzyme
FDA
Sanofi
Isis Pharmaceuticals
advisory panels
Aegerion
Homozygous Familial Hypercholesterolemia
mipomersen
Pharmas Across The Pond
Motley Fool
Sat, 10/13/12 - 12:30 pm
AstraZeneca
GSK
Sanofi
Sanofi Aims to Add Second-Generation Lemtrada to Pipeline
Bloomberg
Fri, 10/12/12 - 12:12 pm
Sanofi
Lemtrada
multiple sclerosis
MS
Genzyme
3 Biotechs Facing the Firing Squad Next Week
Motley Fool
Thu, 10/11/12 - 05:42 pm
Gattex
NPS Pharmaceuticals
lomitapide
Aegerion
Sanofi
Isis Pharmaceuticals
mipomersen
Bristol Myers' Competition Causes Increased Risk
Seeking Alpha
Thu, 10/11/12 - 11:39 am
Bristol-Myers Squibb
Pfizer
Sanofi
Eli Lilly
AstraZeneca
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie

Pages